PATENT CLAIM ANALYSIS

Application Number: 16202487
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "759000"]

Abstract:
The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Claim (Index 7):
A process of making the polymorph of  claim 1  comprising:\n suspending or dissolving 3,3\u2032-Dideoxy-3,3\u2032-bis-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1\u2032-sulfanediyl-di-\u03b2-D-galactopyranoside in an organic solvent; and then \n making polymorphic form 1 by temperature cycling, crash cooling, evaporation, or a combination thereof.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16062206', '15323967', '14438977', '14966427', '13832672']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7328165444879152
- 35 USC 102 Novelty (BERT): 0.6132609340871501
- Combined Prediction Score: 0.7208609834478387
- Mean Citation Score: 303.12529
- Max Citation Score: 551.9757
- Similarity Product: 510.2840911659121

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test